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Abstract: BACKGROUND: Measuring the quality of life measure of patients with dermatologic diseases is an impor-
tant concern. The instruments to evaluate it are commonly originally written in English and need to be translat-
ed and validated to be used in different cultures. 
OBJECTIVE: The purpose of this paper is to translate and validate the Skindex-29 questionnaire to Brazilian
Portuguese to be used in our country as a quality of life assessment instrument in dermatologic patients. 
METHODS: The first step was the translation from English to Brazilian Portuguese and the back-translation by two
native speakers. The translated version was then used for the second step, when three questionnaires were
applied to 75 patients (43 of whom were classified as lightly affected and 32 as heavily affected by their derma-
tologic conditions): an identification questionnaire, the translated version of Skindex-29, and the Brazilian
Portuguese version of Dermatologic Life Quality Index (DLQI). Additionally, the generic questionnaire Short
Form 36 (SF-36) was applied to 41 of these patients. The last step to evaluate reproducibility was repeating the
Skindex-29 questionnaire by the same researcher one week later in 44 patients. 
RESULTS: Reliability was observed in global Skindex-29 scale (α=0.934), and its domains emotions (α=0.926),
symptoms (α=0,702), and psycosocial functioning (α=0.860). The reproducibility showed high intraclass correla-
tions. High intra class correlations was observed, thus validating reliability. 
CONCLUSIONS: The Skindex-29 quality of life questionnaire was properly translated and validated to Brazilian
Portuguese. 
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INTRODUCTION
Measuring the quality of life of patients with
dermatologic diseases is an important and especially
challenging concern.1,2 The most commonly used ins-
truments to assess quality of life were originally writ-
ten in English and need to be translated and adapted
for use in other cultures.3,4,5 Many questionnaires to
evaluate quality of life were designed specifically for
patients with skin conditions.6,7 Disease-specific ins-
truments are preferable to generic health-related qua-
lity of life questionnaires in certain patient popula-
tions, because they are more sensitive to the areas
most affected by the disease.8
Culturally adapting an instrument has many
advantages over writing a new one. For example, it
reduces the costs and the time spent in the writing pro-
cess and allows for using the instrument, which has
been widely used before, to make intercultural compa-
risons.9 It should also be considered that an adapted
questionnaire can be used both for native speaker
patients and for immigrant patients, thus avoiding
selection bias and improving its measuring skills.
In dermatology, studies have shown that
health-related quality of life may be severely reduced
in patients with a wide range of skin diseases such as
atopic dermatitis, psoriasis, leprosy, acne vulgaris,
skin tumors, onychomycosis, and skin ulcers.10-19 On
the other hand, studies in plastic surgery have analy-
zed changes in quality of life caused by surgical pro-
cedures, focusing on breast, nasal, facial and abdomi-
nal procedures.20-25
Daily life domains that may be affected by skin
disease include aspects related to physical and emo-
tional well-being, which may have an impact on social
life and productivity at work and school. The effects
of skin diseases on social interactions and emotional
patterns may be especially relevant, because the
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symptoms of these diseases usually affect patient’s
appearance. Skin disease often has a profound impact
on patient’s life, and medical judgment is not well cor-
related with the perception of affected individuals on
disease severity.26 Thus, measuring the subjective
impact of the disease on the patient becomes particu-
larly important. 
The Skindex-29 is a disease-specific question-
naire that comprehensively assesses the effects of skin
diseases on patient’s quality of life.27 It was specifical-
ly developed to detect changes throughout the time,
as well as differences among patients with different
skin diseases. The questionnaire covers areas conside-
red crucial in an instrument designed to evaluate qua-
lity of life, such as: degree of symptoms, psychosocial
functioning, and emotional status.28,29 The 29-item ver-
sion is a refinement of a previous 61-item version8,27
and combines the advantage of an easier administra-
tion with improved psychometric properties. It was
originally written in English and has already been
translated and validated to other languages: Spanish,
Italian, German, French, Turkish, among others.26,30, 31,32
The aim of the present study was to translate
the Skindex-29 questionnaire to Brazilian Portuguese
and investigate its measuring properties, in order to
allow its use as a quality of life assessment instrument
in patients with dermatologic diseases in Brazil.
METHOD
A preliminary authorization to translate and
validate the questionnaire was obtained from its origi-
nal authors. 
In order to develop a valid Brazilian
Portuguese version of the Skindex-29, the study follo-
wed some guidelines for the cultural adaptation of
health-related quality of life instruments.
The translation phase involved six stages: 
1. Translation of the Skindex-29 into Portuguese by
two English teachers who were Portuguese nati-
ve speakers. 
2. Development of a single Brazilian Portuguese
version by consensus.
3. Back-translation of the first Brazilian Portuguese
version by two American translators unaware of
the study purposes. Comparison of the back-
translated version with the original English lan-
guage instrument. Possible discrepancies were
documented and analyzed by a multidisciplina-
ry committee with regard to their applicability
and cultural equivalence.
4. Evaluation by a multidisciplinary committee:
the committee evaluated both original and
translated versions, as well as filling instructions
and scales. If needed, sentences were rewritten
and scales adjusted until obtaining the second
Brazilian Portuguese version. The committee’s
analysis involved: 
a. Resolution of discrepancies: modifications in
instructions or in the questionnaire format,
modification or rejection of inappropriate items,
and generation of new items.
b.Adjustment of scales: semantic equivalence,
idiomatic equivalence, practical equivalence,
and conceptual equivalence.
5. Pretest of an intermediate Brazilian Portuguese
version in a pilot group of individuals with and
without skin diseases to determine if the transla-
ted version was understandable. In this process,
subjects made comments on the meaning, inter-
pretation and any potential ambiguity for each
item.
6. Translation and back-translation of any proble-
matic item found in the pretest for the genera-
tion of the final Brazilian Portuguese version of
the instrument.
Preliminary evaluation of measuring properties
Specimens
An identification questionnaire, the final
Brazilian Portuguese version of the Skindex-29, and
the Brazilian Portuguese version of the Dermatology
Life Quality Index (DLQI) questionnaire were applied
to 75 adults selected by convenience. Of the total num-
ber of patients, 43 came from the Cosmetolgy outpa-
tient clinic from Casa de Cirurgia Plástica of
Universidade Federal de São Paulo and did not show
facial lesion on the days of data collection(plastic sur-
gery group), 32 came from the Dermatology outpa-
tient clinic of the Universidade Federal de São Paulo,
presented with inflammatory dermatoses such as pso-
riasis or atopic dermatitis and had a facial lesion lar-
ger than 3 cm on the days of data collection (dermato-
logy group). These outpatient clinics were selected
because they had a good number of target patients for
this research.
In order to add one more quality of life ques-
tionnaire for comparison, the last 43 patients of both
clinics answered the Short Form 36 (SF-36) question-
naire. After one week, the Skindex-29 was readminis-
tered by the same evaluator to patients who agreed to
return to the clinic.
The questionnaires were administered during
the month of August, 2011 on the corresponding days
of each outpatient clinic. 
Instruments
For the present validation study, two other qua-
lity of life assessment questionnaires were used along
with the Skindex-29: the DLQI and the SF-36.
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tosis measure, which estimates the degree of flatte-
ning and narrowing of the distribution curve. In these
analyses, approximately normal distribution was not
rejected. 
Intraobserver reproducibility was assessed by
intraclass correlation coefficient and by the Student’s t
test comparing mean scores between the two times
when questionnaires were administered.
RESULTS
First phase: translation
The analysis from the multidisciplinary group
did not show discrepancies between original and
back-translated versions. There was no need of modi-
fying questionnaire instructions or format, modifying
or rejecting inappropriate items, nor generating new
items with significant discrepancies. Thus, no change
in the first translation of the instrument was required,
and the research entered the second phase.
The pretest, administered to 11 patients, did not
find problems of meaning, interpretation and poten-
tial ambiguity, which made it possible to develop the
final version of the Skindex-29 translated into
Brazilian Portuguese (Chart 1).
Second phase: evaluation of measuring properties
According to table 1, patients from both groups
showed a similar distribution in terms of gender and
educational level. Thus, in general, most subjects were
female (76.0%) and had an educational level of up to
high school education (76.1%). Patients’ mean age was
47.8 years (standard deviation=17.8), with a minimum
age of 18 years and a maximum age of 91 years. Both
groups showed similar mean ages (p=0.342).
Assessment of internal consistency of the
Skindex-29
According to table 2, global Skindex-29 score
had excellent reliability (Cronbach’s alpha=0.934), as
well as its dimensions related to emotions (Cronbach’s
alpha=0.926), symptoms, and psychosocial functio-
ning. No significant increase was observed in total
and inter-dimensional Cronbach’s alpha with the
removal of any item from the questionnaire. 
Reproducibility assessment
Table 3 describes mean global Skindex-29 sco-
res and mean scores for each Skindex-29 subscale at
each time of assessment by the same evaluator in 44
patients. According to this table, extremely high intra-
class correlations were observed, which points out to
a good reproducibility. Corroborating this fact, a
strong correlation could be observed between the sco-
res obtained in the two measuring times, with no dif-
ference between means (Graph 1). 
The Skindex-29, a refined version of a previous
61-item questionnaire, is a questionnaire with 29 self-
administered questions that assess the health-related
quality of life of patients with skin diseases. It evalua-
tes three domains: degree of symptoms, psychosocial
functioning, and emotional status. The possible ans-
wers are: never, rarely, sometimes, often, and always,
given in a scale from 1 to 5 points respectively, and the
final scale score is established either by the mean for the
points obtained in the 29 questions (total score) or by
the mean for the items of each domain (domain score).
The DLQI is a brief 10-item health-related qua-
lity of life questionnaire specific for dermatology.33
This is a well-established instrument validated in
Brazil that shows good psychometric properties and
provides a total score.5
The SF-36 is a generic quality of life assessment
instrument that has already been validated in Brazil
and is easy to administer and understand. It is a mul-
tidimensional questionnaire formed by 36 items cove-
ring eight scales or components: physical functioning,
physical role functioning, bodily pain, general health,
vitality, social functioning, emotional role functioning,
and mental health. In addition, it yields a final score
ranging from 0 to 100, in which zero (0) corresponds
to the worst general health status and 100 to the best
general health status.3,34
Statistics
Categorical variables were expressed as absolute
and relative frequencies. The association between two
categorical variables were analyzed using the chi-squa-
re test or, alternatively, the Fisher’s exact test in the case
of small samples. On the other hand, the means of
patients from plastic surgery and dermatology groups
were compared using the Student t test for indepen-
dent samples or the nonparametric Mann-Whitney test
in case of violation of normality assumption. 
The internal consistency between the items that
comprise the Skindex-29 dimensions was expressed as
Cronbach’s alpha coefficients. 
The capacity of the Skindex-29 to investigate
patients’ quality of life in terms of skin (validation) was
evaluated by comparing mean total scores and mean
scores for the different instrument dimensions (emotio-
nal, symptomatic and functional aspects) between plas-
tic surgery and dermatology patients. In addition, this
study aimed to assess the extent to which Skindex-29
scores are associated with other already known and
validated scores, such as those obtained from DLQI and
SF-36 questionnaires, using Spearman’s correlations. 
Variable normal distribution was tested using
the Kolmogorov-Smirnov test, and exploratory data
analysis focused on obliquity (skewness), which mea-
sures the asymmetry of distribution tails, and the kur-
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1- Minha pele dói
2- O estado de minha pele afeta meu sono
3- Fico preocupado(a) que a condição de minha pele possa ser grave
4- A condição de minha pele dificulta meu trabalho e minhas atividades de lazer
5- A condição de minha pele afeta minha vida junto da minha família e amigos
6- O estado de minha pele me deixa com depressão
7- O estado de minha pele provoca sensação de queimadura (ardor ou ferroadas)
8- Eu fico mais em casa por causa da minha pele
9- Eu me preocupo se vou ficar com cicatrizes devido à condição da minha pele
10- Minha pele coca
11- A condição da minha pele afeta o relacionamento com as pessoas que amo
12- Tenho vergonha da condição da minha pele 
13- Fico preocupado que minha pele possa piorar
14- Na maior parte do tempo faço as coisas sozinho(a) por causa da condição da minha pele
15- Fico chateado(a) com o estado da minha pele
16- O contato com a água incomoda minha pele
17- A condição da minha pele dificulta demonstrações de afeto ( carinhos, abraços, beijos)
18- Minha pele está irritada
19- A condição da minha pele afeta meu relacionamento com as outras pessoas
20- Fico constrangido(a) com a condição de minha pele
21- A condição da minha pele é um problema para as pessoas próximas a mim
22- Estou decepcionado(a) ( frustrado) com a condição de minha pele
23- Minha pele é sensível
24- A condição de minha pele muda minha vontade de estar ou não com as pessoas
25- Sinto-me humilhado(a) com a condição de minha pele
26- Minha pele sangra
27- Fico perturbado (a) com a condição de minha pele
28- A condição de minha pele interfere com a minha vida sexual
29- A condição de minha pele me deixa cansado(a)
Para todas as frases as respostas possíveis são: nunca, raramente, às vezes, frequentemente e o tempo todo
CHART 1: Translation of the Skindex-29 into Portuguese 
Characteristics Group Total
Dermatology Plastic surgery
N % N % N %
Gender 32 100.00% 43 100.00% 75 100.00%
Female 24 75.00% 33 76.70% 57 76.00%
Male 8 25.00% 10 23.30% 18 24.00%
x2=0.03 (p=0.861)
Educational level 28 100.00% 39 100.00% 67 100.00%
Elementary school 15 53.60% 13 33.30% 28 41.80%
High school 7 25.00% 16 41.00% 23 34.30%
College education 6 21.40% 10 25.60% 16 23.90%
No data 8
x2=2.94 (p=0.230)
Source adapted: Chren MM, et al. 1996.7
TABLE 1: Distribution of patients' characteristics, according to groups
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Skindex Mean Standard Alpha if Spearman's coefficient 
deviation an item is excluded with score
Item 3 2.27 1.47 0.925 0.696**
Item 6 1.83 1.16 0.92 0.725**
Item 9 2.28 1.58 0.927 0.645**
Item 12 2.29 1.52 0.912 0.834**
Emotions Item 13 2.44 1.6 0.919 0.758**
(Alpha=0.926) Item 15 2.37 1.5 0.909 0.882**
Item 20 2.17 1.41 0.914 0.817**
Item 22 2.23 1.55 0.914 0.794**
Item 25 1.47 1.08 0.926 0.561**
Item 27 1.83 1.28 0.914 0.779**
Item 1 1.27 0.78 0.689 0.394**
Item 7 1.81 1.16 0.654 0.629**
Symptoms Item 10 2.28 1.32 0.6 0.763**
(Alpha= 0.702) Item 16 1.12 0.46 0.699 0.263*
Item 18 2.08 1.19 0.618 0.780**
Item 23 2.85 1.57 0.739 0.626**
Item 26 1.28 0.71 0.664 0.482**
Item 2 1.47 1.03 0.855 0.519**
Item 4 1.97 1.53 0.847 0.705**
Item 5 1.47 1 0.858 0.490**
Item 8 1.57 1.2 0.855 0.627**
Item 11 1.44 1.07 0.85 0.550**
Psychosocial functioning Item 14 1.49 1.18 0.85 0.580**
(Alpha= 0.860) Item 17 1.55 1.2 0.837 0.662**
Item 19 1.59 1.15 0.835 0.665**
Item 21 1.2 0.68 0.854 0.404**
Item 24 1.57 1.16 0.834 0.684**
Item 28 1.4 1.04 0.851 0.505**
Item 29 1.65 1.24 0.856 0.579**
Overall
(Alpha=0.934)
TABLE 2: Summary of Skindex-29 measures (Cronbach's alpha and Spearman's coefficient)
*p<0.05. *p<0.01
Score (mean ± standard deviation) Spearman's correlation Intraclass correlation N
Before After
Emotions 2.51±1.08 2.49±1.12 0.922** 0.933** 44
Symptoms 1.96±0.67 2.03±0.67 0.908** 0.932** 43
Psychosocial functioning 1.72±0.73 1.74±0.74 0.906** 0.899** 44
Total Skindex-29 score 2.06±0.69 2.08±0.70 0.926** 0.937** 43
One patient did not report any information in one of the items from the Symptoms dimension.
Emotions: t=0.298 (p=0.767)
Symptoms: t=1.710 (p=0.095)
Psychosocial functioning: t=0.455 (p=0.652)
Total Skindex score: t=0.510 (p=0.613)
TABLE 3: Mean, Standard Deviation, Spearman's Correlation, and Intraclass Correlation
An Bras Dermatol. 2014;89(4):600-7.
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Scale validation
Graph 2 shows a higher score variability (inter-
quartile range) in the dermatology group than in the
cosmetology group, in addition to the presence of
points outside the curve in the subscales associated
with symptomatic and functional dimensions in the
dermatology group and in emotional, functional and
overall dimensions in the cosmetology group. Graph 3
demonstrates the 95% confidence intervals for mean
values of Skindex scales.
In graph 4, it was possible to observe that, both
for all Skindex-29 domains and for global Skindex-29
score, mean values from the patients heavily affected
by skin diseases (plastic surgery group) were higher
than those from the lightly affected patients (cosmeto-
logy group), revealing that, as expected, the percep-
tion of quality of life related to skin was better in ligh-
tly affected patients than in heavily affected patients. 
According to table 4, the correlation between
Skindex-29 and DLQI was higher than that between
Skindex-29 and SF-36. 
DISCUSSION
The present evaluation of the measuring pro-
perties of the Brazilian Portuguese version of the
Skindex-29 suggests that this questionnaire is a relia-
ble and valid method to quantify the quality of life of
Brazilian patients with skin diseases. The strategy of
translating the original version of the questionnaire
into Brazilian Portuguese, performing a back-transla-
tion into English, and then conducting a pretest follo-
wed the universally accepted steps for the develop-
ment of a conceptually and linguistically equivalent
translation of quality of life questionnaires.8,9,35
Pretesting, including interviews with individuals
from the community and patients, is especially impor-
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tant in the search for an acceptable and intelligible ins-
trument for the general population. In the present
study, the sentences translated into Portuguese did
not need to be modified after the interviews with
patients, which confirms the clarity and objectiveness
of questionnaire items. 
Results also showed that the instrument measu-
res three essential dimensions of quality of life asso-
ciated with skin conditions and that the removal of
any of the items did not lead to significant differences
in the measuring power of the instrument. The dimen-
sions and aspects evaluated in the Skindex seemed to
be similar in the different cultures in which it has
already been validated.
The correlation patterns between Skindex-29
and DLQI confirm the convergent validation evidence
of questionnaires specific for dermatology. A statisti-
cally significant relationship was found when compa-
ring DLQI scores with global Skindex scores and with
the scores for each of Skindex dimensions (Table 4).
On the other hand, when the Skindex-29 was compa-
red with the SF-36, these similarities were not so
expressive. There was a significant correlation only
between the functional domain of the Skindex-29 with
all domains of the SF-36 (except for emotional role
limitation). Similar results were obtained in another
study that compared the 61-item version of the
Skindex with the SF-36.8 This study suggested that the
Skindex-29 would theoretically assess some aspects of
skin diseases more specifically and more accurately
than a general health-related quality of life question-
naire such as the SF-36. This fact is not surprising,
since the Skindex includes items that specifically
investigate the health effects caused by skin disease,
which does not occur with the SF-36, a questionnaire
Scores Spearman's correlation
Total Skindex scores Emotions Symptoms Functioning
DLQI 0.780** 0.665** 0.622** 0.803**
SF-36
Mental health -0.569** -0.471** -0.327* -0.597**
Functional capacity -0.18 -0.021 -0.151 -0.347*
Physical role limitation -0.295 -0.062 -0.265 -0.497**
Bodily pain -0.226 -0.13 -0.035 -0.393**
General health -0.400** -0.259 -0.255 -0.462**
Vitality -0.514** -0.323* -0.387* -0.622**
Social functioning -0.311* -0.259 -0.251 -0.374*
Limitation due to emotional aspects -0.26 -0.169 -0.121 -0.249
*p<0.05. *p<0.01.
Skindex Emotions and Functioning: N=75 patients. Skindex Symptoms and total score: N=74
DLQI: N=75 patients.
SF-36: N=43 (except for Emotional role limitation: N=41).
TABLE 4: Correlation of the Skindex-29 and its subscales with the DLQI and the SF-36
that takes into account only general health dimen-
sions. This ability of the Skindex of specifically asses-
sing quality of life in patients with skin diseases is
shown to be particularly important when a more sen-
sitive instrument is required (e.g., when researchers
aim to compare patients with different skin diseases,
detect changes in the effect of a given dermatosis on
the patient, or perform clinical trials and longitudinal
studies). Similarly, it is important to bear in mind that,
although the Skindex is specific for skin conditions, it
is not specific for any particular disease. Some patho-
logies already have quality of life assessment instru-
ments that have been developed and validated in cer-
tain cultures. When such a specific instrument is avai-
lable and the investigation focuses on a specific skin
disease, this instrument is preferable to the Skindex-
29, although specific and generic questionnaires pro-
vide complementary, not redundant, information. 
Additional studies using the measuring proper-
ties of the Brazilian Portuguese version of the
Skindex-29 will be able to confirm the equivalence of
the present translation. Continuing to adapt the ques-
tionnaire to other cultures and languages will allow
for international comparisons and multicenter stu-
dies, as well as for a possible increase in the quality of
life of patients with skin diseases. The present study
was not appraised by the original authors up to now.
CONCLUSION
The Brazilian Portuguese version of the
Skindex-29 showed significant levels of reproducibili-
ty and validity and thus may be used in Brazil as a
quality of life questionnaire specific for patients with
skin changes. q
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